You are here

Home

Clinical Trials: Myocardial Ischemia

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, September 14, 2021 - 12:00
MSCs for Prevention of MI-induced HF
Conditions:   Myocardial Infarction, Acute;   Myocardial Infarction First;   Myocardial Infarction, Anterior Wall;   Cardiac Remodeling, Ventricular;   STEMI;   Regenerative Medicine;   Heart Failure
Interventions:   Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs);   Other: Conventional Treatment
Sponsors:   Shiraz University of Medical Sciences;   National Institute of Medical Research Development (NIMAD), Iran;   Cell Tech Pharmed Company, Iran
Recruiting
Posted: Monday, August 9, 2021 - 12:00
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury
Conditions:   Ischemic Heart Disease;   Lung Injury;   Non-cardiac Surgery
Interventions:   Biological: human umbilical cord-derived mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Friday, June 25, 2021 - 12:00
Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)
Conditions:   Myocardial Ischemia;   Ventricular Dysfunction, Left
Intervention:   Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, May 27, 2021 - 12:00
PLIN1 Variants in Precocious ACS (SCAPLIN)
Condition:   Acute Coronary Syndrome
Intervention:   Genetic: PLIN1 gene sequencing
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
Posted: Monday, March 1, 2021 - 12:00
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Conditions:   Diabetes Mellitus;   Ischemic Heart Disease
Interventions:   Drug: 100 million Allogeneic Mesenchymal Human Stem Cells;   Other: Placebo
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Thursday, January 28, 2021 - 12:00
Heart Patch for Myocardial Infarction COVID-19
Conditions:   Myocardial Infarction;   Heart Diseases
Intervention:   Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor:   Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Interventions:   Biological: Intravenous infusion placebo;   Biological: Intravenous infusion WJMSCs
Sponsors:   Navy General Hospital, Beijing;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital;   Chinese PLA General Hospital
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease
Condition:   Coronary Artery Disease
Intervention:   Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors:   Navy General Hospital, Beijing;   Chinese PLA General Hospital;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital
Not yet recruiting
Posted: Friday, April 10, 2020 - 12:00
ASC Therapy for Patients With Severe Respiratory COVID-19
Condition:   Respiratory Tract Diseases
Intervention:   Drug: Stem Cell Product
Sponsor:   Rigshospitalet, Denmark
Not yet recruiting
Posted: Thursday, April 9, 2020 - 12:00
Stem Cell in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   PT. Prodia Stem Cell Indonesia
Recruiting

Pages